142 SANSOME STREET, SAN FRANCISCO, CA
89bio, Inc. Enters Merger Agreement with Roche Holdings, Inc.
Announces Agreement to be Acquired by Roche
Reports Second Quarter 2025 Financial Results and Corporate Updates
Shareholder votes
Reports First Quarter 2025 Financial Results and Corporate Updates
Annual Report to Security Holders
Investor Presentation
Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Q2
Q1
FY 2023
Q3
Notice of Late Filing for Annual Report
Effectiveness Notice
Notice of Suspension of Duty to File Reports
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Notification Filed by a National Security Exchange
S-8 POS
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Amended Tender Offer Statement by Third Party
Automatic Shelf Registration Statement
Post-Effective Amendment to Registration Statement